& LeBlanc, J
Meshkat S, Di Luciano C, Swiderski A, Li G, Aguilar RJ, Dunkley BT, Reichelt AC, Zhang Y, Greenshaw A, Vermetten E, Jetly R, Dash S, Agarwal SM, Swainson J, Bhat V (2025) Efficacy and Safety of Glucagon-Like Peptide-1 Agonists for Psychiatric Symptoms: A Systematic Review
With such a large section of society already changing their lives through the use of weight loss injections, new weight loss pills are only set to increase the number of people addressing their own health challenges. James OLoan, CEO and Prescribing Pharmacist at Chemist4U Methodology Consumer survey The research was conducted by Censuswide on behalf of Chemist4U, among a sample of 3,586 UK nationally representative respondents with a minimum of 500 people who have lost weight and 500 people who use weight loss injections
For selected high-risk patients, aspiration-mitigation strategies should be implemented using a multidisciplinary approach
For a specialization-first model, that appears to be working as it exceeds 400 clinics nationwide
Updated data including 28 patients with HER2 -mutant refractory NSCLC showed an ORR of 50% (95% CI, 31 to 69) [24-26]